在美国成年人中,饮食炎症指数与能量调整的饮食炎症指数和便秘之间的关联
Xuelian Zhao1, Xiaoyu Wang2, Longfang Quan3
1Graduated School, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
BMC gastroenterology
|July 26, 2024
概括
高食炎症指数 (DII) 和能量-DII得分与美国成年人便秘风险增加有关. 这些发现凸显了饮食质量对消化系统健康的影响.
科学领域:
- 营养科学 营养科学
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 饮食和炎症是与便秘相关的公认因素.
- 饮食炎症指数 (DII) 和能量-DII以前没有一起评估便秘.
- 这项研究旨在调查美国成年人群中DII,E-DII和便秘之间的关系.
研究的目的:
- 为了检查饮食炎症指数 (DII) 与美国成年人的便秘之间的关联.
- 评估能源-DII (E-DII) 与美国成年人的便秘之间的关系.
- 探索DII和E-DII对便秘发生率的综合影响.
主要方法:
- 利用来自12400名美国成年人 (20岁以上) 的数据,来自国家健康和营养检查调查 (NHANES) (2005-2010).
- 根据每位参与者的两个24小时饮食回忆计算了DII和E-DII得分.
- 使用布里斯托尔便形式尺度定义和分类便秘.
主要成果:
- 在对混因素进行调整后,物流回归模型显示DII和便秘 (OR=1.13,95% CI:1.07-1.20) 和E-DII和便秘 (OR=1.09,95% CI:1.03-1.17) 之间存在显著的正相关性.
- 在DII和E-DII分数中最高四分之一的个体,与最低四分之一的人相比,便秘的患病率更高 (例如,DII的OR=1.79,E-DII的OR=1.75).
- 这些关联在不同性别之间是一致的,并使用多种归算技术证实了这一点.
结论:
- 高的饮食炎症指数 (DII) 与美国成年人便秘的发病率增加有关.
- 较高的能量-DII分数也与美国成年人患便秘的可能性更高有关.
- 这些发现强调了促炎性饮食在便秘发展中的作用.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Chronic Bowel Disorders: Introduction
436
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
436
Inflammatory Bowel Disease II: Crohn's Disease
206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
154
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
154
Drugs for Treatment of Constipation-Predominant IBS
151
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
151


